O	0	8	Appetite	Appetite	JJ	B-NP
O	9	19	regulation	regulation	NN	I-NP
O	20	22	by	by	IN	B-PP
O	23	37	serotoninergic	serotoninergic	JJ	B-NP
O	38	48	mechanisms	mechanism	NNS	I-NP
O	49	52	and	and	CC	I-NP
O	53	60	effects	effect	NNS	I-NP
O	61	63	of	of	IN	B-PP
O	64	65	d	d	NN	B-NP
O	65	66	-	-	HYPH	B-NP
O	66	78	fenfluramine	fenfluramine	NN	I-NP
O	78	79	.	.	.	O

O	80	82	In	In	IN	B-PP
O	83	87	this	this	DT	B-NP
O	88	98	literature	literature	NN	I-NP
O	99	105	review	review	NN	I-NP
O	105	106	,	,	,	O
O	107	115	evidence	evidence	NN	B-NP
O	116	118	is	be	VBZ	B-VP
O	119	128	presented	present	VBN	I-VP
O	129	132	for	for	IN	B-PP
O	133	136	the	the	DT	B-NP
O	137	143	theory	theory	NN	I-NP
O	144	148	that	that	IN	B-SBAR
O	149	152	the	the	DT	B-NP
O	153	169	neurotransmitter	neurotransmitter	NN	I-NP
O	169	170	,	,	,	O
O	171	180	serotonin	serotonin	NN	B-NP
O	181	182	(	(	(	O
O	182	183	5	5	CD	B-NP
O	183	184	-	-	HYPH	I-NP
O	184	201	hydroxytryptamine	hydroxytryptamine	NN	I-NP
O	201	202	,	,	,	O
O	203	206	5HT	5HT	NN	B-NP
O	206	207	)	)	)	O
O	207	208	,	,	,	O
O	209	211	in	in	IN	B-PP
B-Multi-tissue_structure	212	218	medial	medial	JJ	B-NP
I-Multi-tissue_structure	219	231	hypothalamic	hypothalamic	JJ	I-NP
I-Multi-tissue_structure	232	239	centres	centre	NNS	I-NP
O	240	242	is	be	VBZ	B-VP
O	243	245	an	an	DT	B-NP
O	246	255	important	important	JJ	I-NP
O	256	265	regulator	regulator	NN	I-NP
O	266	269	for	for	IN	B-PP
O	270	278	appetite	appetite	NN	B-NP
O	279	282	and	and	CC	B-PP
O	283	286	for	for	IN	B-PP
O	287	290	the	the	DT	B-NP
O	291	300	selection	selection	NN	I-NP
O	301	303	of	of	IN	B-PP
O	304	309	major	major	JJ	B-NP
O	310	314	food	food	NN	I-NP
O	315	327	constituents	constituent	NNS	I-NP
O	327	328	.	.	.	O

O	329	333	High	High	JJ	B-NP
O	334	339	local	local	JJ	I-NP
O	340	346	levels	level	NNS	I-NP
O	347	349	of	of	IN	B-PP
O	350	353	5HT	5HT	NN	B-NP
O	354	359	cause	cause	VBP	B-VP
O	360	361	a	a	DT	B-NP
O	362	371	reduction	reduction	NN	I-NP
O	372	374	of	of	IN	B-PP
O	375	383	appetite	appetite	NN	B-NP
O	384	387	and	and	CC	O
O	388	389	a	a	DT	B-NP
O	390	400	preference	preference	NN	I-NP
O	401	404	for	for	IN	B-PP
O	405	412	protein	protein	NN	B-NP
O	412	413	,	,	,	O
O	414	417	low	low	JJ	B-NP
O	418	424	levels	level	NNS	I-NP
O	425	428	the	the	DT	B-NP
O	429	437	opposite	opposite	NN	I-NP
O	437	438	.	.	.	O

O	439	442	The	The	DT	B-NP
O	443	447	main	main	JJ	I-NP
O	448	460	antagonistic	antagonistic	JJ	I-NP
O	461	467	system	system	NN	I-NP
O	468	470	is	be	VBZ	B-VP
O	471	484	noradrenergic	noradrenergic	JJ	B-ADJP
O	484	485	.	.	.	O

O	486	489	The	The	DT	B-NP
O	490	494	drug	drug	NN	I-NP
O	495	496	d	d	NN	I-NP
O	496	497	-	-	HYPH	B-NP
O	497	509	fenfluramine	fenfluramine	NN	I-NP
O	510	516	mimics	mimic	NNS	I-NP
O	517	520	the	the	DT	B-NP
O	521	528	effects	effect	NNS	I-NP
O	529	531	of	of	IN	B-PP
O	532	535	5HT	5HT	NN	B-NP
O	536	538	by	by	IN	B-PP
O	539	548	releasing	release	VBG	B-VP
O	549	552	5HT	5HT	NN	B-NP
O	553	557	from	from	IN	B-PP
O	558	572	serotoninergic	serotoninergic	JJ	B-NP
B-Cellular_component	573	578	nerve	nerve	NN	I-NP
I-Cellular_component	579	586	endings	ending	NNS	I-NP
O	587	590	and	and	CC	O
O	591	601	inhibiting	inhibit	VBG	B-VP
O	602	605	its	its	PRP$	B-NP
B-Cell	606	614	neuronal	neuronal	JJ	I-NP
O	615	617	re	re	NN	I-NP
O	617	618	-	-	HYPH	B-NP
O	618	624	uptake	uptake	NN	I-NP
O	624	625	.	.	.	O

O	626	633	Further	Further	JJ	B-NP
O	634	646	experimental	experimental	JJ	I-NP
O	647	651	data	datum	NNS	I-NP
O	652	657	prove	prove	VBP	B-VP
O	658	662	that	that	IN	B-SBAR
O	663	664	a	a	DT	B-NP
O	665	669	high	high	JJ	I-NP
O	669	670	-	-	HYPH	I-NP
O	670	682	carbohydrate	carbohydrate	NN	I-NP
O	682	683	,	,	,	O
O	684	687	low	low	JJ	B-NP
O	687	688	-	-	HYPH	I-NP
O	688	695	protein	protein	NN	I-NP
O	696	700	diet	diet	NN	I-NP
O	701	709	promotes	promote	VBZ	B-VP
O	710	716	uptake	uptake	NN	B-NP
O	717	719	of	of	IN	B-PP
B-Organism_substance	720	725	serum	serum	NN	B-NP
O	726	736	tryptophan	tryptophan	NN	I-NP
O	737	739	in	in	IN	B-PP
O	740	743	the	the	DT	B-NP
B-Organ	744	749	brain	brain	NN	I-NP
O	750	753	and	and	CC	O
O	754	757	its	its	PRP$	B-NP
O	758	768	conversion	conversion	NN	I-NP
O	769	773	into	into	IN	B-PP
O	774	777	5HT	5HT	NN	B-NP
O	777	778	.	.	.	O

O	779	784	Hence	Hence	RB	B-ADVP
O	784	785	,	,	,	O
O	786	790	this	this	DT	B-NP
O	791	805	serotoninergic	serotoninergic	JJ	I-NP
O	806	812	system	system	NN	I-NP
O	813	816	may	may	MD	B-VP
O	817	825	function	function	VB	I-VP
O	826	828	as	as	IN	B-PP
O	829	830	a	a	DT	B-NP
O	831	835	self	self	AFX	I-NP
O	835	836	-	-	HYPH	I-NP
O	836	846	regulatory	regulatory	JJ	I-NP
O	847	856	mechanism	mechanism	NN	I-NP
O	856	857	.	.	.	O

O	858	860	In	In	IN	B-PP
O	861	869	patients	patient	NNS	B-NP
O	870	874	with	with	IN	B-PP
O	875	884	decreased	decrease	VBN	B-NP
O	885	895	peripheral	peripheral	JJ	I-NP
O	896	903	insulin	insulin	NN	I-NP
O	904	915	sensitivity	sensitivity	NN	I-NP
O	915	916	,	,	,	O
O	917	920	the	the	DT	B-NP
O	921	927	system	system	NN	I-NP
O	928	931	may	may	MD	B-VP
O	932	934	be	be	VB	I-VP
O	935	944	disturbed	disturb	VBN	I-VP
O	944	945	,	,	,	O
O	946	953	causing	cause	VBG	B-VP
O	954	969	overconsumption	overconsumption	NN	B-NP
O	970	972	of	of	IN	B-PP
O	973	986	carbohydrates	carbohydrate	NNS	B-NP
O	986	987	.	.	.	O

O	988	992	This	This	DT	B-NP
O	993	995	is	be	VBZ	B-VP
O	996	1005	sometimes	sometimes	RB	B-ADJP
O	1006	1016	compulsive	compulsive	JJ	I-ADJP
O	1017	1018	(	(	(	O
O	1018	1019	"	"	``	O
O	1019	1031	carbohydrate	carbohydrate	NN	B-NP
O	1032	1039	craving	crave	VBG	B-VP
O	1039	1040	"	"	''	O
O	1040	1041	)	)	)	O
O	1041	1042	.	.	.	O

O	1043	1045	It	It	PRP	B-NP
O	1046	1049	may	may	MD	B-VP
O	1050	1052	be	be	VB	I-VP
O	1053	1061	presumed	presume	VBN	I-VP
O	1062	1066	that	that	IN	B-SBAR
O	1067	1069	in	in	IN	B-PP
O	1070	1073	the	the	DT	B-NP
O	1074	1083	treatment	treatment	NN	I-NP
O	1084	1086	of	of	IN	B-PP
O	1087	1094	obesity	obesity	NN	B-NP
O	1094	1095	,	,	,	O
O	1096	1098	in	in	IN	B-PP
O	1099	1107	addition	addition	NN	B-NP
O	1108	1110	to	to	TO	B-PP
O	1111	1114	the	the	DT	B-NP
O	1115	1118	use	use	NN	I-NP
O	1119	1121	of	of	IN	B-PP
O	1122	1136	serotoninergic	serotoninergic	JJ	B-NP
O	1137	1142	drugs	drug	NNS	I-NP
O	1142	1143	,	,	,	O
O	1144	1153	successes	successe	VBZ	B-VP
O	1154	1158	with	with	IN	B-PP
O	1159	1167	reducing	reduce	VBG	B-VP
O	1168	1173	diets	diet	NNS	B-NP
O	1174	1177	may	may	MD	B-VP
O	1178	1180	be	be	VB	I-VP
O	1181	1189	enhanced	enhance	VBN	I-VP
O	1190	1192	by	by	IN	B-PP
O	1193	1202	including	include	VBG	B-VP
O	1203	1210	periods	period	NNS	B-NP
O	1211	1213	of	of	IN	B-PP
O	1214	1218	high	high	JJ	B-NP
O	1218	1219	-	-	HYPH	I-NP
O	1219	1231	carbohydrate	carbohydrate	NN	I-NP
O	1231	1232	,	,	,	O
O	1233	1236	low	low	JJ	B-NP
O	1236	1237	-	-	HYPH	I-NP
O	1237	1244	protein	protein	NN	I-NP
O	1245	1251	intake	intake	NN	I-NP
O	1251	1252	.	.	.	O

O	1253	1255	It	It	PRP	B-NP
O	1256	1261	would	would	MD	B-VP
O	1262	1264	be	be	VB	I-VP
O	1265	1275	worthwhile	worthwhile	JJ	B-ADJP
O	1276	1278	to	to	TO	B-VP
O	1279	1286	explore	explore	VB	I-VP
O	1287	1294	whether	whether	IN	B-SBAR
O	1295	1302	similar	similar	JJ	B-NP
O	1303	1313	alimentary	alimentary	JJ	I-NP
O	1314	1318	self	self	AFX	I-NP
O	1318	1319	-	-	HYPH	I-NP
O	1319	1329	regulatory	regulatory	JJ	I-NP
O	1330	1340	mechanisms	mechanism	NNS	I-NP
O	1341	1343	of	of	IN	B-PP
O	1344	1360	neurotransmitter	neurotransmitter	NN	B-NP
O	1361	1369	function	function	NN	I-NP
O	1370	1375	exist	exist	VBP	B-VP
O	1376	1378	in	in	IN	B-PP
O	1379	1384	other	other	JJ	B-NP
O	1385	1395	regulatory	regulatory	JJ	I-NP
O	1396	1403	systems	system	NNS	I-NP
O	1403	1404	.	.	.	O

